Cargando…
ERp29 controls invasion and metastasis of gastric carcinoma by inhibition of epithelial-mesenchymal transition via PI3K/Aktsignaling pathway
BACKGROUND: Gastric cancer (GC) accounts for the fourth most occurring malignancy and the third major cause of cancer death. Identifying novel molecular signaling pathways participating in gastric tumorigenesis and progression is pivotal for rational design of targeted therapies to improve advanced...
Autores principales: | Ye, Jianxin, Huang, Jinsheng, Xu, Jie, Huang, Qiang, Wang, Jinzhou, Zhong, Wenjing, Lin, Xinjian, Li, Yun, Lin, Xu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5585903/ https://www.ncbi.nlm.nih.gov/pubmed/28874138 http://dx.doi.org/10.1186/s12885-017-3613-x |
Ejemplares similares
-
ERp29 inhibits tumorigenicity by suppressing epithelial mesenchymal transition in gastric cancer
por: Wu, Jing, et al.
Publicado: (2017) -
DDAH1 mediates gastric cancer cell invasion and metastasis via Wnt/β‐catenin signaling pathway
por: Ye, Jianxin, et al.
Publicado: (2017) -
Targeting of glutamine transporter ASCT2 and glutamine synthetase suppresses gastric cancer cell growth
por: Ye, Jianxin, et al.
Publicado: (2018) -
Retraction Note: Bone mesenchymal stem cell-derivedexosomal microRNA-29b-3p preventshypoxic-ischemic injury in rat brain byactivating the PTEN-mediated Aktsignaling pathway
por: Hou, Kun, et al.
Publicado: (2020) -
Friend or foe: Endoplasmic reticulum protein 29 (ERp29) in epithelial cancer
por: Chen, Shaohua, et al.
Publicado: (2015)